↓ Skip to main content

Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label…

Overview of attention for article published in The Lancet, August 2017
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (96th percentile)
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

news
5 news outlets
blogs
2 blogs
policy
2 policy sources
twitter
61 X users
facebook
2 Facebook pages

Citations

dimensions_citation
310 Dimensions

Readers on

mendeley
334 Mendeley